Prostaglandin E2 mediates connecting tubule glomerular feedback

Hypertension

Volumn 62, Issue 6, 2013, Pages 1123-1128

  Ren, Yilin ^a   D'Ambrosio, Martin A ^a   Garvin, Jeffrey L ^a,b   Wang, Hong ^a   Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

11,12 epoxy 5,8,14 eicosatrienoic acid; Arachidonic acid; Arterioles; Endothelium; Microcirculation; Prostaglandin E; Prostaglandin E2; Receptors

Indexed keywords

ANTIBODY; ARACHIDONIC ACID; COMPLEMENT; EPOXYICOSATRIENOIC ACID; NORADRENALIN; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; 4-(4-CYANO-2-(2-(4-FLUORONAPHTHALEN-1-YL)PROPIONYLAMINO)PHENYL)BUTYRIC ACID; AMIDE; ARYLBUTYRIC ACID DERIVATIVE; N-METHYLSULFONYL-6-(2-PROPARGYLOXYPHENYL)HEXANAMIDE; NAPHTHALENE DERIVATIVE; 4 (4 CYANO 2 (2 (4 FLUORONAPHTHALEN 1 YL)PROPIONYLAMINO)PHENYL)BUTYRIC ACID; N METHYLSULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; PROSTAGLANDIN E RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONNECTING TUBULE GLOMERULAR FEEDBACK; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL RABBIT; FEEDBACK SYSTEM; GLOMERULUS; KIDNEY TUBULE; MICRODISSECTION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RECEPTOR BINDING; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RABBIT; 11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM;

AMIDES; ANIMALS; ARACHIDONIC ACID; DINOPROSTONE; ENDOTHELIUM, VASCULAR; FEEDBACK, PHYSIOLOGICAL; KIDNEY GLOMERULUS; KIDNEY TUBULES; MICROCIRCULATION; NAPHTHALENES; NOREPINEPHRINE; PHENYLBUTYRATES; RABBITS; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; VASODILATION;

11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; ARACHIDONIC ACID; ARTERIOLES; ENDOTHELIUM; MICROCIRCULATION; PROSTAGLANDIN E2; RECEPTORS, PROSTAGLANDIN E;

EID: 84891613118     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02040     Document Type: Article

References (45)

1. Barajas L, Powers K, Carretero O, Scicli AG, Inagami T. Immunocytochemical localization of renin and kallikrein in the rat renal cortex. Kidney Int. 1986;29:965-970.
2. Vio CP, Figueroa CD, Caorsi I. Anatomical relationship between kallikrein-containing tubules and the juxtaglomerular apparatus in the human kidney. Am J Hypertens. 1988;1(3 Pt 1):269-271.
3. Sipos A, Toma I, Kang JJ, Rosivall L, Peti-Peterdi J. Advances in renal (patho) physiology using multiphoton microscopy. Kidney Int. 2007;72:1188-1191.
4. Ren Y, Garvin JL, Liu R, Carretero OA. Crosstalk between the connecting tubule and the afferent arteriole regulates renal microcirculation. Kidney Int. 2007;71:1116-1121.
5. Ren Y, D'Ambrosio MA, Garvin JL, Wang H, Carretero OA. Possible mediators of connecting tubule glomerular feedback. Hypertension. 2009;53:319-323.
6. Ren Y, D'Ambrosio MA, Garvin JL, Carretero OA. Angiotensin II enhances connecting tubule glomerular feedback. Hypertension. 2010;56:636-642.
7. Ren Y, D'Ambrosio MA, Wang H, Peterson EL, Garvin JL, Carretero OA. Mechanisms of angiotensin II-enhanced connecting tubule glomerular feedback. Am J Physiol Renal Physiol. 2012;303:F259-F265.
8. Wang H, Garvin JL, D'Ambrosio MA, Ren Y, Carretero OA. Connecting tubule glomerular feedback antagonizes tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol. 2010;299:F1374-F1378.
9. Wang H, D'Ambrosio MA, Garvin JL, Ren Y, Carretero OA. Connecting tubule glomerular feedback mediates acute tubuloglomerular feedback resetting. Am J Physiol Renal Physiol. 2012;302:F1300-F1304.
10. Schlondorff D, Ardaillou R. Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int. 1986;29:108-119.
11. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
12. Fuson AL, Komlosi P, Unlap TM, Bell PD, Peti-Peterdi J. Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney. Am J Physiol Renal Physiol. 2003;285:F558-F564.
13. Chatziantoniou C, Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol. 1992;262(1 Pt 2):F68-F76.
14. Tang L, Loutzenhiser K, Loutzenhiser R. Biphasic actions of prostaglandin E (2) on the renal afferent arteriole: role of EP (3) and EP (4) receptors. Circ Res. 2000;86:663-670.
15. Ren Y, Carretero OA, Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension. 2002;39(2 Pt 2):624-628.
16. Burg MB. Perfusion of isolated renal tubules. Yale J Biol Med. 1972;45:321-326.
17. Ito S, Carretero OA. An in vitro approach to the study of macula densamediated glomerular hemodynamics. Kidney Int. 1990;38:1206-1210.
18. Good DW, Wright FS. Luminal influences on potassium secretion: sodium concentration and fluid flow rate. Am J Physiol. 1979;236:F192-F205.
19. Khuri RN, Strieder WN, Giebisch G. Effects of flow rate and potassium intake on distal tubular potassium transfer. Am J Physiol. 1975;228:1249-1261.
20. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883-893.
21. Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M, Hutchins S, Lachance N, Sawyer N, Slipetz D, Metters KM, Rodan SB, Young R, Rodan GA. Prostaglandin receptor EP (4) mediates the bone anabolic effects of PGE (2). Mol Pharmacol. 2001;60:36-41.
22. Schlondorff D. Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am J Med. 1986;81(2B):1-11.
23. Chaudhari A, Gupta S, Kirschenbaum MA. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature. Biochim Biophys Acta. 1990;1053:156-161.
24. Breyer MD, Breyer RM. Prostaglandin receptors: their role in regulating renal function. Curr Opin Nephrol Hypertens. 2000;9:23-29.
25. Imig JD, Breyer MD, Breyer RM. Contribution of prostaglandin EP (2) receptors to renal microvascular reactivity in mice. Am J Physiol Renal Physiol. 2002;283:F415-F422.
26. Villa E, Garcia-Robles R, Haas J, Romero JC. Comparative effect of PGE2 and PGI2 on renal function. Hypertension. 1997;30(3 Pt 2):664-666.
27. Vitzthum H, Abt I, Einhellig S, Kurtz A. Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int. 2002;62:1570-1581.
28. Câmpean V, Theilig F, Paliege A, Breyer M, Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol. 2003;285:F19-F32.
29. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol. 2000;279:F965-F981.
30. Kennedy I, Coleman RA, Humphrey PP, Levy GP, Lumley P. Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins. 1982;24:667-689.
31. Breyer MD, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol. 2000;279:F12-F23.
32. Breyer MD, Zhang Y, Guan Y-F, Hao C-M, Hebert RL, Breyer RM. Regulation of renal function by prostaglandin E receptors. Kidney Int. 1998;54(Suppl 67):S88-S94.
33. Purdy KE, Arendshorst WJ. EP (1) and EP (4) receptors mediate prostaglandin E (2) actions in the microcirculation of rat kidney. Am J Physiol Renal Physiol. 2000;279:F755-F764.
34. Tilley SL, Audoly LP, Hicks EH, Kim HS, Flannery PJ, Coffman TM, Koller BH. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest. 1999;103:1539-1545.
35. Pandit MM, Strait KA, Matsuda T, Kohan DE. Na delivery and ENaC mediate flow regulation of collecting duct endothelin-1 production. Am J Physiol Renal Physiol. 2012;302:F1325-F1330.
36. Arima S, Ren Y, Juncos LA, Carretero OA, Ito S. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int. 1994;45:650-658.
37. Silldorff EP, Yang S, Pallone TL. Prostaglandin E2 abrogates endothelininduced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest. 1995;95:2734-2740.
38. Imig JD, Navar LG. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am J Physiol. 1996;271(1 Pt 2):F87-F93.
39. Purdy KE, Arendshorst WJ. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. Am J Physiol. 1999;277(6 Pt 2):F850-F858.
40. Chatziantoniou C, Arendshorst WJ. Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats. Am J Physiol. 1992;262(1 Pt 2):F124-F130.
41. Juncos LA, Ren Y, Arima S, Garvin J, Carretero OA, Ito S. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow. Kidney Int. 1996;49:374-381.
42. Yoshida H, Tamaki T, Aki Y, Kimura S, Takenaka I, Abe Y. Effects of angiotensin II on isolated rabbit afferent arterioles. Jpn J Pharmacol. 1994;66:457-464.
43. Ichihara A, Imig JD, Inscho EW, Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS. Am J Physiol. 1998;275(4 Pt 2):F605-F612.
44. Cheng HF, Harris RC. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr Pharm Des. 2005;11:1795-1804.
45. Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal antiinflammatory drugs: summary and recommendations. Am J Kidney Dis. 1996;28(1 Suppl 1):S56-S62.